Related Experiment Video
Updated: May 29, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Advances in antiretroviral therapy
Barbara Taylor1, Susan Olender, Timothy J Wilkin
1Division of Infectious Diseases, University of Texas, San Antonio, TX, USA.
The 18th Conference on Retroviruses and Opportunistic Infections highlighted advances in antiretroviral therapy, including new drugs, treatment strategies, and research in resource-limited settings. Key discussions focused on resistance, drug interactions, and prevention of mother-to-child transmission.
Area of Science:
- Infectious Diseases
- Virology
- Public Health
Background:
- The Conference on Retroviruses and Opportunistic Infections (CROI) is a leading scientific meeting.
- Antiretroviral therapy (ART) remains central to managing HIV/AIDS.
- Advances in HIV treatment and prevention are critical globally.
Purpose of the Study:
- To summarize key findings and discussions from the 18th Conference on Retroviruses and Opportunistic Infections.
- To highlight advancements in antiretroviral drug development and clinical application.
- To underscore the importance of ART in diverse settings, including resource-limited areas.
Main Methods:
- Presentations of investigational antiretroviral drugs.
- Reporting of clinical trial data in treatment-experienced patients.
- Discussions on resistance, pharmacokinetics, and adherence.
Main Results:
- Novel antiretroviral drugs and strategies were presented.
- Data on treatment outcomes, resistance, and drug interactions were shared.
- Significant focus on ART scale-up, retention, and outcomes in resource-limited settings.
Conclusions:
- The 18th CROI showcased significant progress in antiretroviral therapy.
- Research presented has implications for both treatment-experienced and new patient populations.
- Global access and adherence to ART, including prevention of mother-to-child transmission, remain critical.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Antiviral Nucleoside Inhibitors
Retroviruses
Inhibitors of Virion Maturation and Assembly
Inhibitors of Viral Protein Synthesis

